Immunogen (IMGN)

Add to Watchlists
Create an Alert
14.17 +1.37  +10.70% NASDAQ Apr 16, 3:26PM BATS Real time Currency in USD

Immunogen Total Expenses (TTM):

106.95M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Immunogen Total Expenses (TTM) Chart

Pro Export Data
Pro Save Image

Immunogen Historical Total Expenses (TTM) Data

Pro Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 106.95M
Sept. 30, 2013 107.76M
June 30, 2013 108.54M
March 31, 2013 108.04M
Dec. 31, 2012 103.68M
Sept. 30, 2012 96.95M
June 30, 2012 89.61M
March 31, 2012 87.05M
Dec. 31, 2011 85.41M
Sept. 30, 2011 84.71M
June 30, 2011 79.49M
   
March 31, 2011 74.56M
Dec. 31, 2010 69.78M
Sept. 30, 2010 66.19M
June 30, 2010 65.18M
March 31, 2010 62.54M
Dec. 31, 2009 59.73M
Sept. 30, 2009 60.05M
June 30, 2009 59.80M
March 31, 2009 Go Pro
Dec. 31, 2008 Go Pro

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Expenses

A company's expenses are how much a company is spending before its net income. This is a useful metric to compare a company spending habits over time. Starting from the income statement, a company may have a considerable amount of revenues. As an investor goes down the Income Statement, gradually line items such as

Cost of Goods Sold,
Research and Development,
Selling, General & Admin,
Depreciation,
and other Expenses

will be subtracted from Revenues. After the aforementioned expenses have been subtracted, we are now at EBIT.

Interest,
Taxes

will be subtracted from EBIT to achieve Net Income. As you can see, there are quite a lot of expenses that are subtracted from a company's revenues before it achieves net income. We've summed the expenses for you to better understand how much a company is spending from its revenues before it hits net income, "the bottom line".

Bear in mind, increasing expenses are not a bad thing at all! If a company's revenues are increasing, there is an almost certain likelihood that expenses are increasing (Think of the phrase "it takes money to make money"). These costs are attributable to selling costs, or just the costs of the goods sold of a manufacturer. A car company might report additional revenues of a car for $30,000, but it will still cost them $15,000 to make! Situations where revenues are not increasing, but expenses are increasing rapidly can be a red flag of potential issues at a company. This metric is often used to compare a specific company over time to see the size of expenses grow quarter by quarter or year by year. Using expenses to compare against competitors can be tricky and not as useful)

This can also be referred to as "total expenses"
Learn More

Get data for
Advertisement

IMGN Total Expenses (TTM) Benchmarks

Companies
Actelion
Jazz Pharmaceuticals 532.11M
Questcor Pharmaceuticals 359.09M

IMGN Total Expenses (TTM) Range, Past 5 Years

Minimum 59.73M Dec 2009
Maximum 108.54M Jun 2013
Average 82.95M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.